These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33272102)

  • 1.
    Thakal S; Singh A; Singh V
    J Biomol Struct Dyn; 2022 Jun; 40(9):4140-4163. PubMed ID: 33272102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
    Thakral S; Singh V
    Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation.
    Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A
    Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, molecular docking and molecular dynamic simulation studies of 2-chloro-5-[(4-chlorophenyl)sulfamoyl]-
    Thakral S; Narang R; Kumar M; Singh V
    BMC Chem; 2020 Dec; 14(1):49. PubMed ID: 32789301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.
    Hameed S; Kanwal ; Seraj F; Rafique R; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Salar U; Taha M; Khan KM
    Eur J Med Chem; 2019 Dec; 183():111677. PubMed ID: 31514061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of 2-amino-4,6-diarylpyrimidine derivatives as potent α-glucosidase and α-amylase inhibitors: structure-activity relationship,
    Mughal EU; Amjid S; Sadiq A; Naeem N; Nazir Y; Alrafai HA; Hassan AA; Al-Nami SY; Abdel Hafez AA; Ali Shah SW; Ghias M
    J Biomol Struct Dyn; 2024; 42(1):244-260. PubMed ID: 37096830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant, Antibacterial, Antidiabetic Potential, and
    Dhakal K; Shrestha D; Pokhrel T; Panta P; Pandey A; Dhakal J; Adhikari A
    Curr Top Med Chem; 2022; 22(26):2145-2151. PubMed ID: 35927822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study.
    Ghannay S; Snoussi M; Messaoudi S; Kadri A; Aouadi K
    Bioorg Chem; 2020 Nov; 104():104270. PubMed ID: 32947132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and In Silico Analysis of New Polyheterocyclic Molecules Derived from [1,4]-Benzoxazin-3-one and Their Inhibitory Effect against Pancreatic α-Amylase and Intestinal α-Glucosidase.
    Ellouz M; Ihammi A; Baraich A; Farihi A; Addichi D; Loughmari S; Sebbar NK; Bouhrim M; A Mothana R; M Noman O; Eto B; Chigr F; Chigr M
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation.
    Ragab A; Salem MA; Ammar YA; Aboulthana WM; Helal MH; Abusaif MS
    Drug Dev Res; 2024 Jun; 85(4):e22216. PubMed ID: 38831547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic.
    Phongphane L; Mohd Radzuan SN; Abu Bakar MH; Che Omar MT; Supratman U; Harneti D; A Wahab H; Azmi MN
    Comput Biol Chem; 2023 Oct; 106():107938. PubMed ID: 37542847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
    Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of pyrrolo[2,3-d]pyrimidine linked hybrids as α-amylase inhibitors: molecular docking, MD simulation, ADMET and antidiabetic screening.
    Zala AR; Tiwari R; Naik HN; Ahmad I; Patel H; Jauhari S; Kumari P
    Mol Divers; 2024 Jun; 28(3):1681-1695. PubMed ID: 37344700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents.
    Acar Çevik U; Celik I; Paşayeva L; Fatullayev H; Bostancı HE; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2023 May; 356(5):e2200663. PubMed ID: 36760015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihyperglycemic potential of pyrazolobenzothiazine 1, 1-dioxide novel derivative in mice using integrated molecular pharmacological approach.
    Taj S; Ashfaq UA; Ahmad M; Noor H; Ikram A; Ahmed R; Tariq M; Masoud MS; Hasan A
    Sci Rep; 2024 Apr; 14(1):7746. PubMed ID: 38565861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.
    Aguila-Muñoz DG; Vázquez-Lira G; Sarmiento-Tlale E; Cruz-López MC; Jiménez-Montejo FE; López Y López VE; Escalante CH; Andrade-Pavón D; Gómez-García O; Tamariz J; Mendieta-Moctezuma A
    Molecules; 2023 May; 28(10):. PubMed ID: 37241920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Antimicrobial and Molecular Docking studies of Some New Derivatives of 2,3-Dihydroquinazolin-4(1H)-one.
    Zahmatkesh K; Dilmaghani KA; Sarveahrabi Y
    Acta Chim Slov; 2022 Sep; 69(3):619-628. PubMed ID: 36196810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and molecular docking studies of imines as α-glucosidase and α-amylase inhibitors.
    Aispuro-Pérez A; López-Ávalos J; García-Páez F; Montes-Avila J; Picos-Corrales LA; Ochoa-Terán A; Bastidas P; Montaño S; Calderón-Zamora L; Osuna-Martínez U; Sarmiento-Sánchez JI
    Bioorg Chem; 2020 Jan; 94():103491. PubMed ID: 31818480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
    Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
    Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.